Clinical pathway in oncological gastric surgery
Conditions
Interventions
Group 1: Patients before CP (Clinical pathway) implementation. Patients were treated regarding the experience and the preference of the surgeon.
Group 2: Patients after CP implementation. Patients wer
Sponsors
Universitätsmedizin Mannheim - Chirurgische Klinik
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients undergoing elective oncological gastrectomy were included. The intervention group (CP group) comprised all consecutive patients operated following the implementation of the CP in October 2012. The control group (pre-CP group) comprised all patients operated in the two years before CP implementation, respectively.
Exclusion criteria
Exclusion criteria: No exclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment and outcome quality for patients undergoing oncological gastrectomy. Process quality was assessed among others by the following parameters: - day of drain or catheter removal - day of mobilization - day of intake of fluids and solids after surgery Outcome quality was assessed among others by the following parameters: - day of discharge - request of analgetics | — |
Secondary
| Measure | Time frame |
|---|---|
| Morbidity (hospital stay and readmission until day 14 after discharge) by assessing postoperative complications (reoperation rate, anastomotic leakage, duodenal stump insufficiency, bleeding, postoperative pancreatic fistulas) according to the Clavien-Dindo classification); mortality (in-hospital mortality) | — |
Countries
Germany
Contacts
Public ContactUlrich Ronellenfitsch
Klinik für Viszeral-, Gefäß- und Endokrine-Chirurgie - Universitätsklinikum Halle (Saale)
Outcome results
None listed